VIR 8-K 2026-11-09

Vir Biotechnology, Inc. (VIR) 8-K dated 2026-11-09 — accession 0001628280-26-071908.

Vir Biotechnology, Inc. (VIR) is a biotechnology company listed on NASDAQ.

Vir Biotechnology, Inc. filed a 8-K on 2026-11-09. Accession 0001628280-26-071908.

This 8-K covers: Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported VIR revenue for 2025-12-31 was $68.6M. Net income was -$438.0M. Revenue was down 7.6% from 2024-12-31 to 2025-12-31. VIR currently screens at market cap $1.45B.

Not investment advice. The VIR SEC hub lists recent forms. The stock page is the research view.